Annaliesa Anderson PhD FAAM, has over 20 years of pharmaceutical research experience and is currently the Chief Scientific Officer for Bacterial Vaccines at Pfizer Inc. Her responsibilities include infectious disease vaccine R and D, surveillance and the assessment of the immunopathology of...

Giuseppe Ciaramella is the Chief Scientific Officer of Valera LLC, a fully owned venture of Moderna that focuses on the discovery of vaccines and therapeutics for Infectious Diseases using Moderna’s mRNA technology. He joined Moderna in January 2014 as VP of Immunology and Biotherapeutics and was...

Professor Sarah Gilbert leads the Jenner Institute’s influenza vaccine programme and has completed the first clinical efficacy study of an influenza vaccine designed to work through cellular immunity, in which vaccine efficacy and a protective T cell phenotype was demonstrated.  The Jenner...

Dr Dianliang Lei is a scientist working in Technology, Norms and Standards of  World Health Organization. He obtained his PhD in medical science in Medical School of Osaka University Japan in 1996. He had been working in the field regulation and quality control of vaccine in the National Institute...

Dr Heidi Meyer is a senior scientist at the Paul-Ehrlich-Institut, the German national regulatory agency responsible for licensing and batch release of vaccines and biomedicines. She is a biologist and holds a Ph.D. in virology. After her university career she worked in the virology laboratories of ...

Mr. Pickering has been responsible for multiple vaccine and immunotherapeutic drug approvals and the formation and financing of multiple successful platform companies. Prior to starting SutroVax, Mr. Pickering was CEO of Mymetics Corporation, a public Swiss-based vaccine company, based on a...

Dr. Jan Poolman is Head Bacterial Vaccine Discovery and Early Development at Janssen Infectious Diseases and Vaccines, at the Janssen Pharmaceutical Companies of Johnson & Johnson. Jan leads the bacterial vaccines team, which focuses on developing vaccines against the most prevalent antibiotics ...

Dr Rino Rappuoli is currently serves as Chief Scientist at GSK vaccines (previously Novartis Vaccines in Siena, Italy, where his former role was the Global Head of Vaccines Research). Prior to this he was Head of R&D for Sclavo and then Head of Vaccine Research and Chief Scientific Officer for...

Dr Jerald C. Sadoff is currently the advisor to the CEO of Janssen, his prior roles include Head of Early Development of the Crucell Vaccine Institute which is the Center of Excellence for Vaccine Development for Johnson & Johnson Companies Worldwide. Dr. Sadoff has spent his entire career...

Dr. Jayanthi Wolf is an immunologist with more than fifteen years of experience in the development of vaccines and biotherapeutics at Merck Research Laboratories.  She is currently a Director in Regulatory Affairs at Merck & Co., Inc., where she provides regulatory leadership for project teams...

Dr Stephen Cook is a Vice President within the GlaxoSmithKline Vaccines Vaccine Global Regulatory Affairs organisation. His role is Head of International Region (Emerging Markets and Asia Pacific / Japan / WHO) In this role, he has responsibility within GSK Vaccines for interactions with the...

Prof. Dr. Stefan H.E. Kaufmann, Director of the Department, born in 1948. Studied Biology at the University of Mainz and graduated as Ph.D. 1977. Habilitation, Free University of Berlin 1981. Positions as Staff Scientist at the Max Planck Institute for Immunobiology, Freiburg, 1982-87, Professor...